1160437-92-2

Upstream product

• 1160437-93-3 (3R,4R,5R)-3-azidomethyl-4-[4-((R)-2-ethoxy-propoxymethyl)-phenyl]-5-[4-(3-methoxy-propyl)-3,4-dihydro-2H-benzo[1,4]oxazin-6-ylmethoxy]-piperidine-1-carboxylic acid tert-butyl ester 
• 303043-57-4 (3R,4R,5S)-3-hydroxy-5-hydroxymethyl-4-(4-hydroxy-phenyl)-piperidine-1-carboxylic acid tert-butyl ester 
• 109989-31-3 methyl (R)-2-ethoxypropanoate 
• 1147886-82-5 (R)-2-ethoxy-1-propanol 
• 1160437-83-1 (3R,4R,5S)-3-hydroxy-5-hydroxymethyl-4-(4-methoxycarbonyl-phenyl)-piperidine-1-carboxylic acid tert-butyl ester 
• 1160437-84-2 (3R,4R,5S)-3-hydroxy-5-hydroxymethyl-4-(4-trifluoromethanesulfonyloxy-phenyl)-piperidine-1-carboxylic acid tert-butyl ester 
• 1160437-82-0 (3R,4R,5S)-3-hydroxy-4-(4-methoxycarbonyl-phenyl)-5-triisopropylsilanyloxymethyl-piperidine-1-carboxylic acid tert-butyl ester 
• 1160437-64-8 (3S,4R,5R)-4-[4-((R)-2-ethoxy-propoxymethyl)-phenyl]-3-hydroxymethyl-5-[4-(3-methoxy-propyl)-3,4-dihydro-2H-benzo[1,4]oxazin-6-ylmethoxy]-piperidine-1-carboxylic acid tert-butyl ester 
• 1160437-78-4 (3R,4R,5S)-4-(4-chloromethyl-phenyl)-3-[4-(3-methoxy-propyl)-3,4-dihydro-2H-benzo[1,4]oxazin-6-ylmethoxy]-5-triisopropyl-silanyloxymethyl-piperidine-1-carboxylic acid tert-butyl ester 
• 1160437-79-5 (3R,4R,5S)-4-(4-hydroxymethyl-phenyl)-3-[4-(3-methoxy-propyl)-3,4-dihydro-2H-benzo[1,4]oxazin-6-ylmethoxy]-5-triisopropylsilanyloxymethyl-piperidine-1-carboxylic acid tert-butyl ester 
• 1160437-77-3 (3R,4R,5S)-4-[4-((R)-2-ethoxy-propoxymethyl)-phenyl]-3-[4-(3-methoxy-propyl)-3,4-dihydro-2H-benzo[1,4]oxazin-6-ylmethoxy]-5-triisopropylsilanyloxymethyl-piperidine-1-carboxylic acid tert-butyl ester 
• 1160437-91-1 (3R,4R,5S)-4-[4-((R)-2-ethoxy-propoxymethyl)-phenyl]-3-[4-(3-methoxy-propyl)-3,4-dihydro-2H-benzo[1,4]oxazin-6-ylmethoxy]-5-(toluene-4-sulfonyloxymethyl)-piperidine-1-carboxylic acid tert-butyl ester 

Relevant academic research and scientific papers

ORGANIC COMPOUNDS

The present invention relates to compounds of the general formula (I) and the salts thereof, preferably the pharmaceutically acceptable salts thereof; in which in which R1 has the meaning explained in the description, a process for their prepar